Total Artificial Heart Market is predicted to gain better growth in coming years 2019 to 2024. This Total Artificial Heart market report provides extensive analysis of top-vendors, regional development, progressive trends, and countless growth statistics of Total Artificial Heart market. Additionally, emerging opportunities and revenue forecast (2019-2024) allows easy decision-making for all readers worldwide.
About Total Artificial Heart
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart.
A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
North America is the largest consumption place, with a consumption market share nearly 61% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 39%.
Covered in this report
According to this study, over the next five years the Total Artificial Heart market will register a 19.7% CAGR in terms of revenue, the global market size will reach US$ 59 million by 2024, from US$ 24 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Total Artificial Heart business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Total Artificial Heart market by product type, application, key manufacturers and key regions and countries.
This study considers the Total Artificial Heart value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
- SynCardia
- Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
- Dilated Cardiomyopathy
- Ischemic Cardiomyopathy
- Others
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- SynCardia
- BiVACOR
- CARMAT
- ReinHeart TAH GmbH
- Cleveland Heart
- AbioMed
- OregonHeart, Inc
Looking for more information on this market? Request a free sample report
Key Topics Covered:
1 Scope of the Report
2 Executive Summary
3 Global Total Artificial Heart by Players
4 Total Artificial Heart by Regions
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Marketing, Distributors and Customer
11 Global Total Artificial Heart Market Forecast
12 Key Players Analysis
13 Research Findings and Conclusion
For more information about this report visit https://www.decisiondatabases.com/ip/43336-total-artificial-heart-market-analysis-report
About DecisionDatabases.com:
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
If you are interested in more information, please contact our media team at sales@decisiondatabases.com
Contacts
DecisionDatabases.com
Phone: 9028057900
Website: http://www.decisiondatabases.com/
No comments:
Post a Comment